Latest Breaking News On - Neomed management - Page 1 : comparemela.com

egnite, Inc and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference

egnite, Inc and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Aliso viejoUnited statesTorrey loperMarissa bychPeijia medicalQatar investment authorityJenavalve technology incBain capital life sciencesValiance life sciencesCompany trilogyStudy ledPresented todayKey findings demonstrate untreated mortality riskSome patientsModerate aortic regurgitationCardiac damage

egnite, Inc and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference

egnite, Inc and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Aliso viejoUnited statesBain capital life sciencesPeijia medicalCompany trilogyQatar investment authorityValiance life sciencesAmerican college of cardiology conferenceJenavalve technology incJenavalve announce novel research on outcomesJenavalve announce novel researchUntreated aortic regurgitationJenavalve technologyAmerican collegeAnnual scientific sessionStructural heart program

egnite, Inc and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference

ALISO VIEJO, Calif. (BUSINESS WIRE) Apr 6, 2024

Aliso viejoUnited statesTorrey loperMarissa bychValiance life sciencesQatar investment authorityJenavalve technology incBain capital life sciencesPeijia medicalCompany trilogyJenavalve technologyAmerican collegeAnnual scientific sessionStructural heart programMorristown medical centerGagnon cardiovascular

egnite, Inc and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference

egnite, Inc and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAliso viejoTorrey loperMarissa bychPeijia medicalQatar investment authorityBain capital life sciencesJenavalve technology incCompany trilogyValiance life sciencesPresented todayFindings demonstrate untreated mortality riskSome patientsModerate aortic regurgitationCardiac damageSevere aortic regurgitation

Transparency Notifications from Shareholders

PRESS RELEASEREGULATED INFORMATION 24 January 2024, 06:00 pm CET Ghent, Belgium – 24 January 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces today that it received transparency notifications from the shareholders listed below, notifying the number of voting rights attached to shares mentioned next to their respective names in the table below. The transpare

United statesDina chayaNeomed iv extension limitedBelgian companiesHoldco incBelgian financial servicesCompany or sequanamedicalNeomed management jersey limitedSequana medicalEuronext brusselsNeomed managementErik ambleClaudio nessiBelgian actBelgian transparency actMarkets authority